 "Alkem IPO price band set at 1,020-1,050 rupees per share")
Indian drugmaker Alkem Laboratories has set the indicative price band for its initial public offering at between 1,020 rupees ($15.33) and 1,050 rupees ($15.78) a share, the company said in a statement on Tuesday.
At the top end of the price band, the offering by Alkem will raise as much as $202.89 million and will value the company at about $1.89 billion, Reuters' calculations showed.
The issue will be open to cornerstone investors on Monday, and a day later for retail investors. The offering will close on December 10, Alkem said in its red herring prospectus on Friday.
($1 = 66.5200 Indian rupees)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app